Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Paulson’s Picks Killed the Market in Q1: Healthcare Stocks Pave the Road to Success

John Paulson’s Paulson & Co had a great first quarter, achieving an average return of 5.6% from its 52 long positions in stocks with a market cap of over $1.0 billion, according to our returns methodology. The hedge fund’s equity portfolio was made up of 62 long positions at the end of the fourth quarter, with 43% of those holdings being in the healthcare industry, and 25% belonging to the consumer discretionary sector. Furthermore, Shire PLC (ADR) (NASDAQ:SHPG), Time Warner Cable Inc (NYSE:TWC), and DIRECTV (NASDAQ:DTV) were Paulson’s top picks at the beginning of 2015, accounting for roughly 21% of the total value of its equity holdings.PAULSON & CO

The strong focus on the healthcare industry was one of the main reasons Paulson & Co was able to beat the market this quarter. While the S&P 500 gained 0.9% in the first quarter, the healthcare sector returned an average 7.22% during the same period. Furthermore, Mr. Paulson’s hedge fund benefited from its investments in the consumer discretionary industry, which returned 6.47% since the beginning of the year.

According to its latest 13F filing, Paulson & Co held 8.33 million shares of Shire PLC (ADR) (NASDAQ:SHPG), valued at around $1.77 billion. The stock ranked as the largest position in the hedge fund’s equity portfolio at the beginning of last quarter, accounting for 9.14% of its total value. Furthermore, Paulson’s top pick had a solid performance during the first quarter, delivering a return of 12.86%, in tune with the average return of 12.13% registered by the biotechnology sector. In addition to Paulson & Co, which ranks as the company’s largest shareholder among institutional investors, numerous hedge funds were betting on Shire PLC (ADR) (NASDAQ:SHPG) this quarter. Peter Rathjens’ Arrowstreet Capital disclosed ownership of 1.28 million shares in its latest 13F filing, while Samuel Islay’s Orbimed Advisors holds 1.17 million shares.

At the beginning of the year, Paulson’s stake in Time Warner Cable Inc (NYSE:TWC) amounted to 8.69 million shares last quarter. The position was valued at roughly $1.32 billion, representing 6.82% of the hedge fund’s equity portfolio. Despite Paulson’s bullish stance (the investment firm increased its exposure to the stock by 1.37 million shares during the fourth quarter), shares of Time Warner Cable Inc (NYSE:TWC) lost 0.44% during the first quarter. Furthermore, the company is set to be taken over by Comcast Corporation (NASDAQ:CMCSA) for $45.2 billion once the acquisition is approved by the Federal Communications Commission and U.S. Department of Justice. While Paulson & Co holds a significant stake in the company, Chris Hohn’s Children’s Investment Fund is even more invested in Time Warner Cable. Mr. Hohn’s fund held 9.87 million shares of stock as of the end of 2014, valued at $1.50 billion, and accounting for almost 60% of its equity portfolio.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.